Cigna Group (NYSE:CI – Get Free Report) was upgraded by Wall Street Zen from a “hold” rating to a “buy” rating in a research report issued on Saturday.
Several other equities research analysts also recently weighed in on the company. Wolfe Research reaffirmed an “outperform” rating and set a $315.00 price target on shares of Cigna Group in a research report on Tuesday. Piper Sandler lowered their target price on Cigna Group from $370.00 to $346.00 and set an “overweight” rating on the stock in a research note on Wednesday, June 3rd. Jefferies Financial Group dropped their target price on Cigna Group from $333.00 to $330.00 and set a “buy” rating on the stock in a report on Monday, April 20th. Robert W. Baird set a $337.00 price target on Cigna Group in a research report on Friday, May 1st. Finally, Mizuho boosted their price target on Cigna Group from $330.00 to $340.00 and gave the company an “outperform” rating in a report on Monday, June 8th. One analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $338.30.
Check Out Our Latest Report on CI
Cigna Group Stock Up 0.1%
Cigna Group (NYSE:CI – Get Free Report) last issued its earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.60 by $0.19. The firm had revenue of $68.52 billion during the quarter, compared to analysts’ expectations of $66.29 billion. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The firm’s revenue was up 4.6% compared to the same quarter last year. During the same quarter last year, the company posted $6.74 earnings per share. Cigna Group has set its FY 2026 guidance at 30.350- EPS. As a group, equities research analysts forecast that Cigna Group will post 30.39 earnings per share for the current year.
Insider Activity at Cigna Group
In other news, CAO Jamie G. Kates sold 899 shares of the company’s stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $298.61, for a total transaction of $268,450.39. Following the completion of the transaction, the chief accounting officer directly owned 2,368 shares of the company’s stock, valued at $707,108.48. This represents a 27.52% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CEO David Cordani sold 201,878 shares of Cigna Group stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the completion of the sale, the chief executive officer directly owned 34,337 shares in the company, valued at $10,054,560.34. This represents a 85.46% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is currently owned by company insiders.
Institutional Inflows and Outflows
Several hedge funds have recently added to or reduced their stakes in CI. Wilkerson Advisory Group LLC acquired a new stake in shares of Cigna Group in the fourth quarter valued at about $25,000. Beacon Financial Strategies CORP acquired a new position in Cigna Group during the fourth quarter worth about $28,000. Kemnay Advisory Services Inc. purchased a new stake in Cigna Group during the 4th quarter valued at about $29,000. Prosperity Bancshares Inc purchased a new stake in Cigna Group during the 4th quarter valued at about $29,000. Finally, Cedar Mountain Advisors LLC raised its holdings in Cigna Group by 161.9% in the 1st quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock valued at $29,000 after acquiring an additional 68 shares during the last quarter. 86.99% of the stock is owned by institutional investors and hedge funds.
About Cigna Group
Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
Read More
- Five stocks we like better than Cigna Group
- Aehr Spikes on New Order, But Has Stock Gotten Ahead of Itself?
- Rackspace’s AI Land Grab: Plugging Into the Next Compute Boom
- Satellogic Is Tiny But Its Revenue Growth Is Hard to Ignore
- Why Kroger’s Pullback Could Be a Gift for Patient Investors
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
